Plenty of money changed hands in pharma M&A during March, with the biggest deal a $6.7 billion merger between Mallinckrodt ...

Germany's largest pharma company, today reported a currency-adjusted 6.1% gain in full-year 2024 revenues, buoyed by its ...

Freed from their former obligations to remain loyal to agency and state, a number of high-profile figures from the US Food ...

US healthcare giant Johnson & Johnson’s (NYSE: JNJ) venture capital arm has made its first investment in South Korea, leading ...

French drugmaker Sanofi (Euronext: SAN) has appointed Chris Corsico as its new global head of development, according to an ...

Danish biotech Gubra (CPSE: GUBRA) saw its share gains more than 8% to 448.00 kroner, after it announced positive results ...

The European Medicines Agency (EMA) announced it is exploring improvements to the development and evaluation of biosimilar ...

Japanese drugmaker Sumitomo Pharma said yesterday that it is divesting its Asian business to major Japanese trading house ...

French biotech Transgene (EPA: TNG) has named Simone Steiner as its new chief technical officer, in a move aimed at advancing ...

UK-based clinical-stage biopharmaceutical company Cerevance has announced top-line results from the Phase II ASCEND trial of solengepras as an investigational monotherapy in patients with early, ...

The European Medicines Agency (EMA) has granted Priority Medicine (PRIME) designation to radiprodil, an investigational, potent negative allosteric modulator selectively targeting the ...

A biotech company advancing next-generation precision therapeutics for fibrosis. Forth Therapeutics (Forth Tx) is a ...